Evidence map›Paper›PMID 35783686›Full record

ArticleOpen forum infectious diseases2022

High Rates of Asymptomatic

Alexander Ring, Suraj Balakrishna, Frank Imkamp, Sara Burkard, Flurina Triet, Flurina Brunschweiler, Christina Grube, Rebecca Bodmer, Roger D Kouyos, Huldrych F Günthard and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00537966 (Characterization of Acute and Recent HIV-1 Infections in Zurich. a Long-term Observational Study), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00537966 recruitingnot on this map

Characterization of Acute and Recent HIV-1 Infections in Zurich. a Long-term Observational Study: the Zurich Primary HIV Infection Study.

Typeobservational_patient_registrySponsorUniversity of ZurichRan2002 to 2028Enrolled800ConditionsHIV Infections
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Drug resistance ofFrontiers in cellular and infection microbiology · 2026
    Review
  3. Tropical medicine and infectious disease · 2025
    Article
  4. Article
  5. Article
  6. Prevalence of Site-SpecificInfection and drug resistance · 2025
    Article
  7. Prevalence ofSexually transmitted infections · 2024
    Article
  8. To Screen or Not to Screen-Controversies in Testing forJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  9. Article
  10. Prevalence ofOpen forum infectious diseases · 2024
    Article
  11. High Prevalence of Asymptomatic STIs in MSM PWH in a Male HIV Clinic in Mexico City.Journal of the International Association of Providers of AIDS Care
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alexander RingDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-0092-1323
Suraj BalakrishnaDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Frank ImkampInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Sara BurkardDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Flurina TrietDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Flurina BrunschweilerDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Christina GrubeDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Rebecca BodmerInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Roger D KouyosDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9220-8348
Huldrych F GünthardDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Dominique L BraunDivision of Infectious Disease and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Participants of the Zurich Primary HIV Study (ClinicalTrials.gov Identifier NCT00537966) were systematically offered screening for sexually transmitted infections (STIs) between April 2019 and September 2020. Screening was performed using an in-house polymerase chain reaction panel comprising Results: We screened 148 of 266 (55.6%) participants, with an overall total of 415 follow-up visits. Ninety-one percent were MSM. The incidence rate for all STIs was 47.0 (95% confidence interval [CI], 32.2-68.6) per 100 person-years. Conclusions: The high prevalence of mostly asymptomatic

Indexed as

antibiotic resistanceMycoplasma genitaliumprimary HIV-1-infectionscreeningsexually transmitted infection

Identifiers

PMID35783686
PMCPMC9246285
OpenAlexW4225005402

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.